<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>long COVID &#8211; UF Innovate</title>
	<atom:link href="https://innovate.research.ufl.edu/tag/long-covid/feed/" rel="self" type="application/rss+xml" />
	<link>https://innovate.research.ufl.edu</link>
	<description>Building business on innovation</description>
	<lastBuildDate>Tue, 12 Aug 2025 04:16:31 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://innovate.research.ufl.edu/wp-content/uploads/favicon-blue_1.png</url>
	<title>long COVID &#8211; UF Innovate</title>
	<link>https://innovate.research.ufl.edu</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Research Underway To Treat COVID-19 Long Hauler Syndrome</title>
		<link>https://innovate.research.ufl.edu/neobiosis-research-covid19-longhauler/</link>
		
		<dc:creator><![CDATA[Sara Dagen]]></dc:creator>
		<pubDate>Thu, 21 Jan 2021 00:00:00 +0000</pubDate>
				<category><![CDATA[Accelerate @ Sid Martin Biotech]]></category>
		<category><![CDATA[News Brief]]></category>
		<category><![CDATA[UF COVID-19]]></category>
		<category><![CDATA[UF Innovate]]></category>
		<category><![CDATA[COVID-19 long hauler syndrome]]></category>
		<category><![CDATA[long COVID]]></category>
		<category><![CDATA[Neobiosis]]></category>
		<category><![CDATA[Post-COVID syndrome]]></category>
		<category><![CDATA[regenerative medicine]]></category>
		<guid isPermaLink="false">https://scaddev1.com/neobiosis-research-covid19-longhauler/</guid>

					<description><![CDATA[In this article, UF Innovate &#124; Sid Martin Biotech resident client Neobiosis founder Ian White explains how his company is using regenerative medicine to develop products to treat coronavirus long hauler syndrome. (Note: the University of Florida Innovate Center mentioned in the story should be UF Innovate &#124; Sid Martin Biotech.)]]></description>
										<content:encoded><![CDATA[
<p class="wp-block-paragraph"><em>In this article, UF Innovate | Sid Martin Biotech resident client Neobiosis founder Ian White explains how his company is using regenerative medicine to develop products to treat coronavirus long hauler syndrome. (Note: the University of Florida Innovate Center mentioned in the story should be UF Innovate | Sid Martin Biotech.)</em></p>



<hr class="wp-block-separator" />



<p class="wp-block-paragraph">Throughout the pandemic, millions of people have felt relief after recovering from COVID-19, but for some, the feeling is short-lived as new symptoms appear or old ones linger.</p>



<p class="wp-block-paragraph">Known as &#8220;long COVID&#8221; or long hauler syndrome, patients are reporting a wide range of symptoms.</p>



Read more about <a href="https://www.thedenverchannel.com/rebound/coronavirus-stress/research-underway-to-treat-covid-19-long-hauler-syndrome">Research Underway To Treat COVID-19 Long Hauler Syndrome.</a>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
